Advantage Trust Company’s Bristol-Myers Squibb BMY Stock Holding History

Advantage Trust Company’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98K	Hold	1,700	–	–	0.03%	85
2026 Q1	$103K	Sell	1,700 -374	-18%	-$21.8K	0.05%	56
2025 Q4	$112K	Sell	2,074 -58	-3%	-$2.79K	0.05%	53
2025 Q3	$96.2K	Sell	2,132 -261	-11%	-$12.2K	0.04%	83
2025 Q2	$111K	Hold	2,393	–	–	0.05%	83
2025 Q1	$146K	Sell	2,393 -82	-3%	-$4.78K	0.09%	52
2024 Q4	$140K	Hold	2,475	–	–	0.08%	53
2024 Q3	$128K	Hold	2,475	–	–	0.09%	52
2024 Q2	$103K	Sell	2,475 -27	-1%	-$1.21K	0.07%	67
2024 Q1	$136K	Hold	2,502	–	–	0.1%	58
2023 Q4	$128K	Buy	+2,502	New	+$131K	0.1%	60

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Advantage Trust Company's BMY Position: Q2 2026 in Review

Advantage Trust Company held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 1,700 shares worth $98K. The position accounts for 0.03% of the portfolio, ranked #85.

Advantage Trust Company first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $146K in Q1 2025. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Advantage Trust Company held 1,700 shares of Bristol-Myers Squibb worth $98K as of Q2 2026.
Advantage Trust Company left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.03% of Advantage Trust Company's portfolio in Q2 2026, its #85 holding.
Advantage Trust Company first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Advantage Trust Company's Bristol-Myers Squibb position peaked at $146K in Q1 2025.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.